ANTI-CD40 ANTIBODY CONSTRUCTS WITH HIGH INTRINSIC AGONISM Application WO-2024062092-A1 World Intellectual Property Organisation (WIPO) 28 Mar 2024
COMBINATION THERAPY Application WO-2022152701-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR… Application WO-2021048135-A1 World Intellectual Property Organisation (WIPO) 18 Mar 2021